Gate Insights and Crypto Market Analysis

Gate Insights features in-depth crypto analysis, market trends, and long-form articles to help you understand key movements across the crypto industry.

Canada's Big Six Banks Report Q3 Earnings This Week

Canada's Big Six banks report third-quarter earnings this week. Bank shares have risen between 20% and 35% year to date, setting high expectations for results. Analysts warn that strong valuations increase the risk of volatility if banks fail to meet forecasts. The banks have navigated tariff
TD-1.36%
BMO-0.79%
RY-0.70%
LucasBennett·09-02 06:33
Canada's Big Six Banks Report Q3 Earnings This Week

Mirae Asset Launches First Tokenized ETF in Hong Kong on August 27

Mirae Asset Asset Management's Hong Kong entity launched a tokenized share class for its 'Global X HSCEI Covered Call Active ETF' on August 27, in collaboration with Citi and digital asset platform OSL, marking the first tokenized covered call ETF in Hong Kong. BlackRock introduced tokenized money m
BLK-0.37%
RWA3.36%
LucasBennett·09-02 06:21
Mirae Asset Launches First Tokenized ETF in Hong Kong on August 27

Trader 0x89da Opens $44.85M Long Position on Ethereum After 7-Month Break

Trader 0x89da opened a 25x long position on 18,587 ETH valued at approximately $44.85 million after a seven-month hiatus from trading. The move was highlighted by CryptoTwitter commentator @lookonchain. Ethereum has experienced a consolidation phase following a bullish rally that peaked in
ETH2.15%
CryptoFrontier·09-02 06:13
Trader 0x89da Opens $44.85M Long Position on Ethereum After 7-Month Break

Marex Group Enters Korea Market with AA- Rating, Targets Derivatives

British global financial group Marex Group (Nasdaq: MRX) obtained an 'AA-' credit rating from a domestic Korean credit rating agency and is entering the Korean structured derivatives market. The company plans to target back-to-back hedging of equity derivatives for Korean securities firms and the
BTC0.44%
GS-0.03%
LucasBennett·09-02 06:04
Marex Group Enters Korea Market with AA- Rating, Targets Derivatives

La Liga: Real Sociedad vs. Celta — Can the 50% Probability of a Home Win Materialize? What Is the Gate Event Market Predicting?

On September 4, 2026, at 03:00 (UTC+8), La Liga Matchday 2 will feature a highly anticipated matchup, with Real Sociedad hosting Celta at Anoeta Stadium. With the new season only entering its second matchday, both teams are still searching for their best form. Real Sociedad opened the season with a 2-1 away win over Espanyol, while Celta endured a difficult start, earning just 1 point from their first two matches and failing to win either of their opening home games. In the Gate Event Market, th
GateInstantTrends·09-02 06:04
La Liga: Real Sociedad vs. Celta — Can the 50% Probability of a Home Win Materialize? What Is the Gate Event Market Predicting?

X Investigates Password-Reset Wave Following X Money Rollout

X product engineer Mridul Singhai said on Sept. 1 the company is investigating a wave of unsolicited password-reset emails and verification codes sent to users, and has found no evidence of any breaches. Singhai tied the activity to attackers testing accounts now that X Money is widely available; th
V-1.00%
CryptoFrontier·09-02 06:02
X Investigates Password-Reset Wave Following X Money Rollout

US Treasury ETFs in Korea Drop 5% as Long-Term Yields Surge

US Treasury bond ETFs listed on the Korean stock exchange recorded losses of approximately 5% over one month as US long-term Treasury yields maintained elevated levels. As of the close on September 1, major 30-year Treasury ETFs fell between 4.83% and 5.73% over the past month, with six-month losses
LucasBennett·09-02 05:45
US Treasury ETFs in Korea Drop 5% as Long-Term Yields Surge

Alteogen Signs $3.2B Novartis Deal for ALT-B4 Subcutaneous Drug Tech

Alteogen [stock code 196170] signed an option and license agreement with Novartis on the 2nd for the development and commercialization of ALT-B4-based subcutaneous formulation drugs utilizing Hybroza technology. The contract value reaches a maximum of $3.223 billion (approximately ₩4.4165
LucasBennett·09-02 05:30
Alteogen Signs $3.2B Novartis Deal for ALT-B4 Subcutaneous Drug Tech